Combined telomerase inhibitor and gemcitabine for the treatment of cancer

• 收藏
• 分享

专利权人:

GERON CORPORATION

发明人:

GO, NING,TRESSLER, ROBERT J.

申请号：

DK07867297

公开号：

DK2101789T3

申请日:

2007.10.30

申请国别(地区):

DK

年份:

2015

代理人:

摘要：

A method and kit for inhibiting the proliferation of cancer cells are disclosed, based on a combination of a gemcitabine and a telomerase inhibitor. When used in cancer therapy, the two compounds in combination enhance the anti-cancer treatment efficacy obtained with gemcitabine alone or the telomerase inhibitor alone. Preferably, efficacy is supraadditive or synergistic in nature relative to the combined effects of the individual agents, with minimal exacerbation of side effects.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/